Hemlibra 150 mg/mL Solution for Injection
*- Company:Roche Registration GmbH
- Status:No Recent Update
- Legal Category:Product subject to medical prescription which may not be renewed (A)
- Active Ingredient(s):- *Additional information is available within the SPC or upon request to the company 

 Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product. 
- (Click to Download) - Hemlibra (emicizumab): Laboratory Professional Guide- Risk Minimisation Materials
- (Click to Download) - Hemlibra (emicizumab): Healthcare Professional Guide Important Risk Minimisation Information for Healthcare Professionals- Risk Minimisation Materials
Roche Registration GmbH

- Address:3004 Lake Drive, Citywest, Naas Road, Dublin 24
- Medical Information E-mail:ireland.druginfo@roche.com
- Telephone:+353 1 469 0700
- Fax:+353 1 469 0791
